Verastem, Inc. (VSTM): Price and Financial Metrics
VSTM Price/Volume Stats
| Current price | $3.79 | 52-week high | $14.22 |
| Prev. close | $3.96 | 52-week low | $2.10 |
| Day low | $3.74 | Volume | 458,700 |
| Day high | $4.00 | Avg. volume | 593,432 |
| 50-day MA | $3.28 | Dividend yield | N/A |
| 200-day MA | $6.28 | Market Cap | 168.68M |
VSTM Stock Price Chart Interactive Chart >
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
VSTM Price Returns
| 1-mo | 10.82% |
| 3-mo | 54.07% |
| 6-mo | -8.01% |
| 1-year | -41.06% |
| 3-year | -88.96% |
| 5-year | -71.80% |
| YTD | -53.44% |
| 2023 | 68.53% |
| 2022 | -80.37% |
| 2021 | -3.76% |
| 2020 | 58.96% |
| 2019 | -60.12% |
Continue Researching VSTM
Here are a few links from around the web to help you further your research on Verastem Inc's stock as an investment opportunity:Verastem Inc (VSTM) Stock Price | Nasdaq
Verastem Inc (VSTM) Stock Quote, History and News - Yahoo Finance
Verastem Inc (VSTM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...